Volume 109, Issue 1, Pages 165–171
Fangyin Meng, M.D., Ph.D., Gregory Zapantis, M.D., Samuel Z. Williams, M.D., Ph.D., Harry J. Lieman, M.D., Erkan Buyuk, M.D., U. Thomas Meier, Ph.D.
To assess whether nucleolar channel systems (NCSs) can be detected in exfoliated endometrial epithelial cells (EECs) of uterine secretions and whether such noninvasively determined NCS status is associated with significant NCS prevalence in simultaneously obtained endometrial biopsies.
Prospective study (December 2015–February 2017).
University-affiliated and private fertility clinics.
Luteal-phase patients of reproductive age requiring endometrial biopsy for medical indications.
Uterine secretion aspiration before endometrial biopsy. Cells in uterine secretions were spun onto slides and fixed. NCSs were identified and quantified in cells and paraffin-embedded tissue sections by indirect immunofluorescence.
Main Outcome Measure(s)
Comparison of NCS status of uterine secretions with NCS prevalence in biopsies. Based on NCS detection, uterine secretions were assigned a status of NCS-positive (n = 15) or NCS-negative (n = 7). NCS prevalence in biopsies was expressed as a percentage of NCSs per EECs.
NCSs can be detected in exfoliated EECs of uterine secretions. Median NCS prevalence in endometrial biopsies from patients with NCS-positive secretions was 41.9% (interquartile range [IQR], 21.1–53.9) versus 2.0% (IQR, 0–6.9) when secretions were NCS-negative. The NCS status of secretions identified a significant difference in NCS prevalence of simultaneously obtained biopsies.
NCS status of secretions accurately reflects NCS prevalence of biopsies, a marker for the implantation window. As secretion aspiration is compatible with same-day ET, our study provides proof of principle for a minimally invasive approach to determine endometrial receptivity for timing frozen ET.